Similar to NCZ treatment, PBZ showed enhanced cytotoxicity and reduced chemotherapeutic resistance through ERK1/2-dependent HSF1 in colorectal cancer cells [84]. This evidence concerns the gene MAPK3 and colorectal cancer.